.svg){kind=small}
May-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
In May 2026, Eighth Brother, Inc. concentrated 46.37% of sales in Flower with year-over-year change at -38.34% and month-over-month movement at 5.39%, while Vapor Pens held 28.20% share with -33.18% YoY and 15.12% MoM. Pre-Roll accounted for 15.87% share but declined -51.36% YoY and -3.99% MoM, and Edible at 7.94% share fell -41.62% YoY and -2.36% MoM; Concentrates were 1.62% share with -51.30% YoY yet a 76.17% MoM spike. With the brand’s overall sales at -40.11% YoY and average price down -0.37% YoY, the mix tilts toward two categories with improving MoM momentum (Vapor Pens and Flower) while Pre-Roll and Edible continue to drag, implying the near-term volume recovery is concentrated in inhalable formats despite broad YoY contraction.
The concentration in Flower (46.37% share) coupled with a 5.39% MoM uptick and the 15.12% MoM lift in Vapor Pens (28.20% share) suggests Eighth Brother, Inc. is leaning into core inhalables where price tolerance near $15.42 in Flower and $9.75 in Vapor Pens supports traffic even as YoY declines persist at -38.34% and -33.18%. Conversely, a -3.99% MoM dip in Pre-Roll and -2.36% MoM in Edible, alongside steeper YoY drops of -51.36% and -41.62%, points to deprioritization or weaker pull in value-driven segments with lower average prices around $3.90–$4.12; the 76.17% MoM surge in Concentrates from a 1.62% base indicates a tactical niche rather than a mix pivot. Net effect: the brand’s positioning in California Flower at rank 31 and the consolidation around two inhalable pillars implies a focus on defending shelf relevance where momentum exists, rather than broadening into lagging value segments.
Competitive Landscape
Eighth Brother, Inc. sits at rank #31 in CA Flower in May 2026, down 10 positions year over year from #21 and 4 positions from its February 2026 rank of #27, despite having reached a peak of #9 in July 2024; meanwhile, CAM climbed from #4 to #1 with 46.9% YoY sales growth and STIIIZY held #2 while expanding sales 39.7% YoY, outpacing Eighth Brother, Inc.’s trajectory by widening the gap at the top. In contrast, CannaBiotix (CBX) slid from #1 to #3 with an 8.3% YoY sales decline, yet Eighth Brother, Inc. still moved from #21 to #31 as competitors like Allswell advanced from #5 to #4 with 16.1% YoY growth and Blem improved from #6 to #5 with 19.4% YoY growth, signaling that Eighth Brother, Inc.’s continued multi-quarter rank erosion and loss of relative momentum point to share being ceded to faster-growing leaders.
Notable Products
Green Crack Pre-Roll (1g) posted the largest movement in May 2026 with +85.19% MoM to rank 4, while Venom OG Pre-Roll (1g) fell -34.43% MoM at rank 8, signaling a sharp divergence within the same format. Blue Dream Distillate Disposable (1g) held rank 1 with +18.51% MoM, and across the top ten, six SKUs are Pre-Roll entries versus four Vapor Pens, indicating a tilt toward flower formats even as the leading revenue driver remains a pen. This mix implies Eighth Brother, Inc. is balancing momentum in value-seeking Pre-Rolls with a flagship Vapor Pen anchor, positioning assortment around traffic-driving joints while preserving premium pen share.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
